Sánchez M, Novella-Maestre E, Teruel J, Ortiz E, Pellicer A. (2008). «The Valencia programme for fertility preservation». Clin Transl Oncol.10. doi:10.1007/s12094-008-0227-4. 433-438. []
Mandavilli A. (2008). «New techniques preserve fertility hope for women.». Nature Medicine14 (1170).[7]
nih.gov
ncbi.nlm.nih.gov
Apperley JF, Reddy N. (1995). «Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy.». Blood Rev.9 (2). 93-116.[1]
Viviani S, Santoro A, Ragni G, Bonfante V, Bestetti O, Bonadonna G. (1985). «Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD.». Eur J Cancer Clin Oncol.21 (5). 601-5.[4]
Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, van Langendonckt A. (2004). «Livebirth after orthotopic transplantation of cryopreserved ovarian tissue.». Lancet364 (9443). 1405-10.[8]
Cobo A, Bellver J, Domingo J, Pérez S, Crespo J, Pellicer A, Remohí J. (2008). «New options in assisted reproduction technology: the Cryotop method of oocyte vitrification.». Reprod Biomed Online17 (1). 68-72.[9]
Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M. (2003). «Trends in breast cancer by race and ethnicity.». CA Cancer J Clin.53 (6). 342-55.[3]
wiley.com
www3.interscience.wiley.com
Jemal A, Clegg LX, Ward E, Ries LA, Wu X, Jamison PM, Wingo PA, Howe HL, Anderson RN, Edwards BK. (2004). «Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival.». Cancer101 (1). 3-27.[2]
